Unknown

Dataset Information

Utility of conventional clinical risk scores in a low-risk COVID-19 cohort.


ABSTRACT:

Background

Several specific risk scores for Coronavirus disease 2019 (COVID-19) involving clinical and biochemical parameters have been developed from higher-risk patients, in addition to validating well-established pneumonia risk scores. We compared multiple risk scores in predicting more severe disease in a cohort of young patients with few comorbid illnesses. Accurately predicting the progression of COVID-19 may guide triage and therapy.

Methods

We retrospectively examined 554 hospitalised COVID-19 patients in Singapore. The CURB-65 score, Pneumonia Severity Index (PSI), ISARIC 4C prognostic score (4C), CHA2DS2-VASc score, COVID-GRAM Critical Illness risk score (COVID-GRAM), Veterans Health Administration COVID-19 index for COVID-19 Mortality (VACO),

SUBMITTER: Ngiam JN 

PROVIDER: S-EPMC8542362 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature